Report overview
This report contains market size and forecasts of Coagulation Factor XI in Global, including the following market information:
Global Coagulation Factor XI Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Coagulation Factor XI market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MR-1007 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Coagulation Factor XI include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Coagulation Factor XI companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coagulation Factor XI Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Type, 2021 (%)
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Global Coagulation Factor XI Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Application, 2021 (%)
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Global Coagulation Factor XI Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Coagulation Factor XI Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coagulation Factor XI revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Coagulation Factor XI revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
